Immix Biopharma, Inc. - stock earnings
IMMX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.3 million USD | ? USD |
| 2023Q2 | -3.6 million USD | ? USD |
| 2023Q1 | -2.5 million USD | ? USD |
| 2022Q4 | -3.8 million USD | -89.5 million USD |
| 2022Q3 | -1.5 million USD | ? USD |
| 2022Q2 | -1.6 million USD | ? USD |
| 2022Q1 | -1.3 million USD | ? USD |
| 2021Q4 | -22.8 million USD | ? USD |
| 2021Q3 | -403265 USD | ? USD |
| 2021Q2 | -208638 USD | ? USD |
| 2021Q1 | -1.0 million USD | ? USD |
| 2020Q4 | -765578 USD | ? USD |
| 2020Q3 | -116320 USD | ? USD |
IMMX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -14.1 million USD | ? USD |
| 2022 | -8.2 million USD | -89.5 million USD |
| 2021 | -24.4 million USD | ? USD |
| 2020 | -1.1 million USD | ? USD |
| 2019 | -972811 USD | ? USD |
IMMX
Price: $2.13
52 week price:
Earnings Per Share: -0.89 USD
P/E Ratio: -3.08
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 12035
Market Capitalization: 72.9 million